HANNAH MANZANO: Open Payments
NPI 1417795295 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,847 in 207 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $621 · 2025 $2,847
Food & beverage: $2,847
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 40 | $670 |
| ABBVIE INC. | 53 | $443 |
| Lilly USA, LLC | 21 | $273 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $211 |
| GlaxoSmithKline, LLC. | 12 | $191 |
| PFIZER INC. | 15 | $176 |
| Sumitomo Pharma America, Inc. | 9 | $172 |
| Dexcom, Inc. | 11 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $122 |
| Amgen Inc. | 5 | $88 |
Products named: Ozempic, MOUNJARO, Kerendia, Wegovy, NURTEC ODT, GEMTESA, Dexcom G6 Transmitter, QULIPTA.
Industry payments across TX — which companies pay providers there.
